Skin Research Innovations Skin Research Innovations


Galderma is committed to meeting the dermatological needs of patients by developing innovative molecules, formulations and delivery systems.

  • Adapalene: Differin® (adapalene) Lotion 0.1% Pump, Differin® (adapalene) Gel 0.3% Pump and Epiduo® (adapalene and benzoyl peroxide) Gel 0.1%/2.5% Pump
  • Brimonidine: Mirvaso® (brimonidine) Topical gel, 0.33%
  • Calcitrol: Vectical® (calcitriol) Ointment 3 mcg/g
  • Doxycycline: Oracea® (doxycycline) Capsule 40mg (30mg immediate release & 10 mg delayed release beads)
  • Hydroquinone: Tri-Luma® (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) Cream
  • Lidocaine/ Tetracaine: Pliaglis® (lidocaine/tetracaine) Cream 7%/7%
  • Metronidazole: MetroGel® (metronidazole) Gel 1% Pump

© 2013-2016 Galderma Laboratories, L.P. United States, All trademarks are the property of their respective owners. All Rights Reserved. This site intended for U.S. audiences only.

Custom Photography by: © Stewart Cohen Pictures and TOM HUSSEY Photography, LLC

Corporate site | Privacy | Legal | Compliance Program | Site Map